Thrita
Thrita

article information

Thrita: Vol.11, issue 1; e123356
published online: June 5, 2022
article type: Research Article
received: February 14, 2022
revised: February 28, 2022
accepted: March 13, 2022
DOI: https://doi.org/10.5812/thrita-123356
Crossmark

The Effects of Chlorpyrifos on Hippocampal Caspase-3 Levels and Passive Avoidance Memory in Rats

authors:

avatar Sina Nikbin 1 , 2 , avatar Seyed Behnamedin Jameie 2 , avatar Mohammad Ali Azarbayjani ORCID 1 , avatar Nasrin Hosseini 2 , *

Department of Exercise Physiology, Faculty of Physical Education and Sport Sciences, Central Tehran Branch, Islamic Azad University, Tehran, Iran
Neuroscience Research Center, Iran University of Medical Sciences, Tehran, Iran

how to cite: Nikbin S, Jameie S B , Azarbayjani M A, Hosseini N. The Effects of Chlorpyrifos on Hippocampal Caspase-3 Levels and Passive Avoidance Memory in Rats. Thrita. 2022;11(1):e123356. https://doi.org/10.5812/thrita-123356.

Abstract

Background:

Chlorpyrifos is an organophosphate pesticide that is widely used in the world. Exposure to chlorpyrifos is associated with some problems in cognitive functions, such as learning and memory. Caspase-3 is a cysteine protease that is activated in response to several apoptotic stimuli and triggers some proteolytic events, cell death, and neurodegeneration.

Objectives:

The aim of the present study was to clear potential mechanisms related to chlorpyrifos neurotoxicity through caspase-3 alteration and passive avoidance memory function.

Methods:

Male adult rats were randomly divided into the control, sham, and chlorpyrifos groups (eight rats in each group). The chlorpyrifos group received an intraperitoneal injection of chlorpyrifos (3 mg/kg/5 days) dissolved in dimethyl sulfoxide for two consecutive weeks. The caspase-3 levels in the hippocampus were assessed by the western blot technique, and also the passive avoidance task was used for memory evaluation.

Results:

Our findings showed that chlorpyrifos treatment markedly increased caspase-3 levels in the hippocampus and also increased the time spent in the dark chamber 24 h and one week after receiving foot shock in the chlorpyrifos group.

Conclusions:

Organophosphate pesticides exposure can impair passive avoidance memory, and high levels of caspase-3 in the hippocampus are proposed as a possible reason for neuronal toxicity and memory impairment.

1. Background

Organophosphates insecticides, such as chlorpyrifos (CPF), have been widely used as insecticides around the world. CPF is also frequently used in agriculture; therefore, it can be easily found in water, food, and air. CPF can be accumulated in humans and distributed throughout the body (1). Moreover, animal experiments demonstrated some neurotoxic effects of CPF exposure. Animals also showed cognitive impairments in the open-field, visual signal detection, Morris water maze, 16-arm radial, and T-maze tasks (2).

The hippocampus is directly or indirectly involved in learning and memory. Moreover, neurodegeneration often leads to the loss of cognitive functions and dementia. Studies have reported that injuries to cerebral and hippocampal neural cells are critical to inducing cognition impairment. Besides, programmed cell death has been proposed as a reason for neurodegeneration (3, 4). Uncontrolled neural apoptosis events in the brain, specifically in the cortex and hippocampus, promote learning and memory impairment (5). Studies have documented that the overproduction of reactive oxygen species (ROS) by brain mitochondria is a key factor in triggering apoptosis in the brain (6).

Overproduction of ROS or low levels of antioxidants can result in protein oxidation, lipid peroxidation, and mitochondrial DNA damage, leading to the dysfunction of many biological events (7).

The caspase gene family, including caspase-3, is involved in several important apoptosis pathways and also proteolytic events in neuronal cells. Caspase-3 has both apoptotic and non-apoptotic roles and is a regulatory molecule in neurogenesis and synaptic activity in neural differentiation (8, 9).

Findings are limited about the impacts of CPF on apoptotic alterations and cognitive functions in the brain, specifically the hippocampus (10-12). CPF can affect the antioxidant capacity and ROS production. Studies have documented that CPF exposure caused events such as low antioxidant capacity, high ROS levels, and activation of apoptosis cascades. These factors are involved in the development of some neurodegenerative diseases (13).

Previous studies have reported different behavioral tests to determine learning and memory function; thus, it is hard to study repeated CPF exposure effects on cognitive functions. In this line, subjects in studies showed conflicting behaviors regarding the effects of CPF exposure (14-18). In this regard, it is necessary to pay more attention to the effects of CPF on different types of memory, such as working memory, and biochemical mediators, such as caspase-3.

2. Objectives

Our study was designed to evaluate the chlorpyrifos effects on passive avoidance memory and caspase-3 alterations in the hippocampus.

3. Methods

3.1. Animals

Male Wistar rats (Rattus norvegicus, 180 - 220 g) were provided from the Pasteur Institute of Iran. Animals were placed in cages (four animals per cage) with available food and water and under physiological lighting) 12-h light/dark cycle). The animal house temperature was set as 23 ± 3°C. In all experiments, the Laboratory Animal Care Principals were followed (NIH guideline, No. 80-23, Updated1996). The study protocol was approved by the bioethical board of the Islamic Azad University, Central Tehran Branch, Tehran, Iran. This project is a part of a larger project (Iriau.iaug.rec1398.008).

3.2. Chemicals

CPF [CAS No. 2921-88-2] was provided from Sigma-Aldrich Co. (St. Louis, MO, USA), and dimethyl sulfoxide (DMSO) was purchased from Merck (Darmstadt, Germany). Initially, CPF was dissolved and diluted in dimethyl-sulfoxide (DMSO) and 0.9% normal saline (the final DMSO concentration was 0.01% v/v).

3.3. Animal Groups

Animals were randomly divided into three groups, including control, sham, and CPF groups (eight in each). The control group did not receive the intervention. Animals in the CPF group received intraperitoneal CPF (3.0 mg/kg) for five days per week (single daily injection) for two consecutive weeks, while the sham group received the vehicle with the same volume of DMSO diluted in 0.9% normal saline. The CPF volume for injection was selected according to our pilot study results (data are not presented in this study) and Yan et al.’s study, based on the highest toxicity and the lowest animal death (2). In the experimental group, animals received CPF for two weeks (five days per week), and the passive avoidance test was done after a one-week treatment. At the end of the experiments, animals were sacrificed, and the hippocampus was removed for western blot analysis.

3.4. Passive Avoidance Test

Short- and mid-term memory was evaluated by the passive avoidance behavioral task. The shuttle box included two compartments with similar dimensions (light or dark side; 20 × 80 × 20 cm). There was a movable door (7 × 9 cm) between the light and dark rooms. The dark room was floored with stainless steel rods. Electric shocks with the frequency of 50 Hz, length of 1.5 s, and intensity of 1.5 - 2 mA were delivered through a stimulator. After the habituation session, each rat was placed in the light room, and the door was opened after 5 s so that the subject could move freely in the dark or light room. When the rat entered the dark side, the door was immediately closed, and the rat received an electrical shock for 3 s. After 24h, the subject was placed in the light chamber, and the latency to enter the dark chamber was documented. Animals that avoided the dark room for a maximum of 5 min were considered with acceptable avoidance memory.

3.5. Western Blot Procedure

The RIPA buffer (radioimmunoprecipitation assay buffer) was used to homogenize hippocampus [Triton X-100 (1%), Tris–HCl (0.01m), and pH 7.4, NaCl (0.15 m), EDTA 19 (ethylene diamine tetraacetic acid;10 - 03 m), SDS (Sodium Dodecyl Sulfate; 0.01%), and protease inhibitor cocktail (0.1%)]. The homogenates were centrifuged for 10 min at 4°C (10,000 × g). Collected samples were used for protein detection. Total protein extracts were treated in SDS buffer [mercaptoethanol (10%), glycerol (20%), Tris–HCl (0.125 m,) and SDS (4%), pH: 6.8]. Then, the samples were exposed to SDS-polyacrylamide gel-electrophorese, immunoblotting with polyclonal antibodies of rabbit against procaspase-3, cytochrome C, and beta-actin (1:1000 dilutions), and Horseradish peroxidase-conjugated secondary antibody (1: 10,000 dilutions). All proteins were identified through Luminol (Santa Cruz).

3.6. Statistical Analysis

The results were analyzed by SPSS (version 20) using one-way ANOVA followed by Tukey post-hoc test. The results are reported as mean ± SD, and significance was considered at < 0.05.

4. Results

4.1. Caspase-3 Analysis

Figure 1 represents the hippocampal caspase-3 levels in all experimental groups. There were no significant differences between the control and sham groups. Therefore, drug solvents did not affect caspase-3 levels. However, caspase-3 significantly increased in the CPF group compared with the control and sham groups (both P < 0.001).

The caspase-3 levels in the experimental groups [*** P < 0.001, significant difference between the control and CPF groups; ††† P < .001, significant difference between the sham and CPF groups; The data are shown as mean ± SD (n = 8 in each group)].
The caspase-3 levels in the experimental groups [*** P < 0.001, significant difference between the control and CPF groups; ††† P < .001, significant difference between the sham and CPF groups; The data are shown as mean ± SD (n = 8 in each group)].
Figure 1.

The caspase-3 levels in the experimental groups [*** P < 0.001, significant difference between the control and CPF groups; ††† P < .001, significant difference between the sham and CPF groups; The data are shown as mean ± SD (n = 8 in each group)].

4.2. Behavioral Results

The data of passive avoidance experiments in all groups are represented in Figure 2. There were no significant differences between the groups in the latency to enter the dark room 24h and one week after receiving an electrical foot shock. Also, the CPF group significantly spent more time in the dark room compared to the control and sham groups, 24h and one week after receiving the foot shock (P < 0.01 and P < 0.05, respectively). Our results showed that short- memory and mid-term memory consolidation was impaired by CPF because latency presents memory and the dark room stay time shows memory consolidation.

The effects of chlorpyrifos (CPF) on passive avoidance test. A, Latency to enter the dark room 24 hours and one week after receiving the foot shock) (** P < .01, significant difference between the control and CPF groups; † P < .05, significant difference between the sham and CPF groups); B, Time spent in the dark room 24 hours and one week after receiving the foot shock [*** P < 0.001, significant difference between the control and CPF groups; † P < 0.05, significant difference between the sham and CPF groups; The data are shown as mean ± SD (n = 8 in each group)].
The effects of chlorpyrifos (CPF) on passive avoidance test. A, Latency to enter the dark room 24 hours and one week after receiving the foot shock) (** P < .01, significant difference between the control and CPF groups; † P < .05, significant difference between the sham and CPF groups); B, Time spent in the dark room 24 hours and one week after receiving the foot shock [*** P < 0.001, significant difference between the control and CPF groups; † P < 0.05, significant difference between the sham and CPF groups; The data are shown as mean ± SD (n = 8 in each group)].
Figure 2.

The effects of chlorpyrifos (CPF) on passive avoidance test. A, Latency to enter the dark room 24 hours and one week after receiving the foot shock) (** P < .01, significant difference between the control and CPF groups; † P < .05, significant difference between the sham and CPF groups); B, Time spent in the dark room 24 hours and one week after receiving the foot shock [*** P < 0.001, significant difference between the control and CPF groups; † P < 0.05, significant difference between the sham and CPF groups; The data are shown as mean ± SD (n = 8 in each group)].

5. Discussion

This study investigated the harmful impacts of CPF on short- and mid-term memory and caspase-3 levels in the hippocampus. The results of this study revealed that CPF exposure impaired short- and mid-term memory in the CPF group compared to the control group.

Although human and animal studies have reported some cognitive dysfunctions, such as memory and attention impairment, anxiety, and other mood disorders after exposure to CPF (19, 20), more research is still needed. In the present study, intraperitoneal CPF injections (3.0 mg/kg) for five days per week for two consecutive weeks led to retrieval memory impairment 24 h and one week after receiving foot shock in CPF-treated rats.

Previous studies have reported conflicting results on the effects of using different doses of CPF and durations of treatment on motor activity, behavioral tasks, and memory in animals. For example, repeated exposure to CPF at 40 mg/kg for four days caused no motor activity impairment, while exposure to CPF at 0, 1, 3, and 10 mg/kg for four weeks and 15 mg/kg for four weeks led to motor activity dysfunction (14, 15, 18). Moreover, 0, 1, 3, and 10 mg/kg of CPF for four weeks and 1 and 5 mg/kg for one year caused no measurable impairments in attention, learning, and memory in delayed matching to position task, while repeated oral administration of CPF for eight weeks (12.5 mg/kg/5 days) caused learning impairment (16) and spatial memory impairment (17). In this line, our results showed that CPF treatment (3.0 mg/kg/5days) for two weeks impaired passive avoidance memory task. The conflicting results appear to be due to the use of different doses, treatment duration, and different behavioral tasks in the studies because different neurobehavioral processes are influenced by the type of behavioral tasks.

Previous studies have demonstrated hippocampal neurodegeneration as the main cause of learning and memory impairment in neurodegenerative diseases (21). They have also proposed that apoptosis is involved in hippocampal neuronal cell death (3). It seems that apoptosis and related neuronal cell loss have major roles in cognitive dysfunction and memory impairment. In this regard, CPF induced apoptosis in embryonic and newborn cortical neurons of rats (22).

Apoptosis is necessary for the development of nervous system for postmitotic neurons and neuronal precursor elimination (23), and caspases-3 is a key effector in cell apoptosis regulation (24, 25). To confirm the involvement of caspases-3 in CPT-induced apoptosis, we assessed its level in the hippocampus. In the present study, the CPF-treated group was found with increased caspase-3 levels in the hippocampus, suggesting that CPF enhanced apoptosis in the hippocampus. In line with this, it has been revealed that caspase-3 is one of the critical proteases in self-activating, anti-Fas, and staurosporine-related apoptosis (26). In some apoptotic pathways, caspase-3 is activated by cytochrome c, and ROS also can induce cytochrome c release. Therefore, it seems that a chain of events, including caspase-3 activation, cytochrome c release, and ROS production, contribute in apoptosis (26).

5.1. Conclusion

In summary, the present study showed that CPF exposure (3 mg/kg for five days) for two weeks caused short- and long-term memory consolidation in rats, while it did not affect latency. Also, caspase-3 levels increased in CPF-treated rats, which is involved in cell apoptosis events and neurodegeneration. It seems that caspase-3 plays a role in memory impairment; however, more investigations are needed.

Acknowledgements

References

  • 1.

    Jantunen AP, Tuikka A, Akkanen J, Kukkonen JV. Bioaccumulation of atrazine and chlorpyrifos to Lumbriculus variegatus from lake sediments. Ecotoxicol Environ Saf. 2008;71(3):860-8. [PubMed ID: 18353437]. https://doi.org/10.1016/j.ecoenv.2008.01.025.

  • 2.

    Yan C, Jiao L, Zhao J, Yang H, Peng S. Repeated exposures to chlorpyrifos lead to spatial memory retrieval impairment and motor activity alteration. Neurotoxicol Teratol. 2012;34(4):442-9. [PubMed ID: 22640976]. https://doi.org/10.1016/j.ntt.2012.05.053.

  • 3.

    D'Amelio M, Cavallucci V, Cecconi F. Neuronal caspase-3 signaling: not only cell death. Cell Death Differ. 2010;17(7):1104-14. [PubMed ID: 19960023]. https://doi.org/10.1038/cdd.2009.180.

  • 4.

    Nakandakari S, Munoz VR, Kuga GK, Gaspar RC, Sant'Ana MR, Pavan ICB, et al. Short-term high-fat diet modulates several inflammatory, ER stress, and apoptosis markers in the hippocampus of young mice. Brain Behav Immun. 2019;79:284-93. [PubMed ID: 30797044]. https://doi.org/10.1016/j.bbi.2019.02.016.

  • 5.

    Kuhn HG, Biebl M, Wilhelm D, Li M, Friedlander RM, Winkler J. Increased generation of granule cells in adult Bcl-2-overexpressing mice: a role for cell death during continued hippocampal neurogenesis. Eur J Neurosci. 2005;22(8):1907-15. [PubMed ID: 16262630]. https://doi.org/10.1111/j.1460-9568.2005.04377.x.

  • 6.

    Muller WE, Eckert A, Kurz C, Eckert GP, Leuner K. Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease--therapeutic aspects. Mol Neurobiol. 2010;41(2-3):159-71. [PubMed ID: 20461558]. https://doi.org/10.1007/s12035-010-8141-5.

  • 7.

    Lovell MA, Markesbery WR. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res. 2007;35(22):7497-504. [PubMed ID: 17947327]. [PubMed Central ID: PMC2190704]. https://doi.org/10.1093/nar/gkm821.

  • 8.

    Faherty CJ, Xanthoudakis S, Smeyne RJ. Caspase-3-dependent neuronal death in the hippocampus following kainic acid treatment. Brain Res Mol Brain Res. 1999;70(1):159-63. [PubMed ID: 10381555]. https://doi.org/10.1016/s0169-328x(99)00143-6.

  • 9.

    Boudreau MW, Peh J, Hergenrother PJ. Procaspase-3 Overexpression in Cancer: A Paradoxical Observation with Therapeutic Potential. ACS Chem Biol. 2019;14(11):2335-48. [PubMed ID: 31260254]. [PubMed Central ID: PMC6858495]. https://doi.org/10.1021/acschembio.9b00338.

  • 10.

    Moreno M, Canadas F, Cardona D, Sunol C, Campa L, Sanchez-Amate MC, et al. Long-term monoamine changes in the striatum and nucleus accumbens after acute chlorpyrifos exposure. Toxicol Lett. 2008;176(2):162-7. [PubMed ID: 18164878]. https://doi.org/10.1016/j.toxlet.2007.11.003.

  • 11.

    Aldridge JE, Seidler FJ, Slotkin TA. Developmental exposure to chlorpyrifos elicits sex-selective alterations of serotonergic synaptic function in adulthood: critical periods and regional selectivity for effects on the serotonin transporter, receptor subtypes, and cell signaling. Environ Health Perspect. 2004;112(2):148-55. [PubMed ID: 14754568]. [PubMed Central ID: PMC1241823]. https://doi.org/10.1289/ehp.6713.

  • 12.

    Slotkin TA. Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. Toxicol Appl Pharmacol. 2004;198(2):132-51. [PubMed ID: 15236950]. https://doi.org/10.1016/j.taap.2003.06.001.

  • 13.

    Newman EL, Gupta K, Climer JR, Monaghan CK, Hasselmo ME. Cholinergic modulation of cognitive processing: insights drawn from computational models. Front Behav Neurosci. 2012;6:24. [PubMed ID: 22707936]. [PubMed Central ID: PMC3374475]. https://doi.org/10.3389/fnbeh.2012.00024.

  • 14.

    Mattsson JL, Wilmer JW, Shankar MR, Berdasco NM, Crissman JW, Maurissen JP, et al. Single-dose and 13-week repeated-dose neurotoxicity screening studies of chlorpyrifos insecticide. Food Chem Toxicol. 1996;34(4):393-405. [PubMed ID: 8641666]. https://doi.org/10.1016/0278-6915(96)00121-4.

  • 15.

    Chakraborti TK, Farrar JD, Pope CN. Comparative neurochemical and neurobehavioral effects of repeated chlorpyrifos exposures in young and adult rats. Pharmacol Biochem Behav. 1993;46(1):219-24. [PubMed ID: 7504821]. https://doi.org/10.1016/0091-3057(93)90344-s.

  • 16.

    Cohn J, MacPhail RC. Chlorpyrifos produces selective learning deficits in rats working under a schedule of repeated acquisition and performance. J Pharmacol Exp Ther. 1997;283(1):312-20. [PubMed ID: 9336338].

  • 17.

    Samsam TE, Hunter DL, Bushnell PJ. Effects of chronic dietary and repeated acute exposure to chlorpyrifos on learning and sustained attention in rats. Toxicol Sci. 2005;87(2):460-8. [PubMed ID: 16033991]. https://doi.org/10.1093/toxsci/kfi264.

  • 18.

    Maurissen JP, Shankar MR, Mattsson JL. Chlorpyrifos: lack of cognitive effects in adult Long-Evans rats. Neurotoxicol Teratol. 2000;22(2):237-46. [PubMed ID: 10758353]. https://doi.org/10.1016/s0892-0362(99)00062-8.

  • 19.

    Mackenzie Ross SJ, Brewin CR, Curran HV, Furlong CE, Abraham-Smith KM, Harrison V. Neuropsychological and psychiatric functioning in sheep farmers exposed to low levels of organophosphate pesticides. Neurotoxicol Teratol. 2010;32(4):452-9. [PubMed ID: 20227490]. [PubMed Central ID: PMC3042861]. https://doi.org/10.1016/j.ntt.2010.03.004.

  • 20.

    Roldan-Tapia L, Nieto-Escamez FA, del Aguila EM, Laynez F, Parron T, Sanchez-Santed F. Neuropsychological sequelae from acute poisoning and long-term exposure to carbamate and organophosphate pesticides. Neurotoxicol Teratol. 2006;28(6):694-703. [PubMed ID: 17029710]. https://doi.org/10.1016/j.ntt.2006.07.004.

  • 21.

    Mu Y, Gage FH. Adult hippocampal neurogenesis and its role in Alzheimer's disease. Mol Neurodegener. 2011;6:85. [PubMed ID: 22192775]. [PubMed Central ID: PMC3261815]. https://doi.org/10.1186/1750-1326-6-85.

  • 22.

    Caughlan A, Newhouse K, Namgung U, Xia Z. Chlorpyrifos induces apoptosis in rat cortical neurons that is regulated by a balance between p38 and ERK/JNK MAP kinases. Toxicol Sci. 2004;78(1):125-34. [PubMed ID: 14691213]. https://doi.org/10.1093/toxsci/kfh038.

  • 23.

    Ryan CA, Salvesen GS. Caspases and neuronal development. Biol Chem. 2003;384(6):855-61. [PubMed ID: 12887052]. https://doi.org/10.1515/BC.2003.096.

  • 24.

    Hwang L, Choi IY, Kim SE, Ko IG, Shin MS, Kim CJ, et al. Dexmedetomidine ameliorates intracerebral hemorrhage-induced memory impairment by inhibiting apoptosis and enhancing brain-derived neurotrophic factor expression in the rat hippocampus. Int J Mol Med. 2013;31(5):1047-56. [PubMed ID: 23503673]. https://doi.org/10.3892/ijmm.2013.1301.

  • 25.

    De Zio D, Giunta L, Corvaro M, Ferraro E, Cecconi F. Expanding roles of programmed cell death in mammalian neurodevelopment. Semin Cell Dev Biol. 2005;16(2):281-94. [PubMed ID: 15797838]. https://doi.org/10.1016/j.semcdb.2004.12.003.

  • 26.

    Higuchi M, Honda T, Proske RJ, Yeh ET. Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases. Oncogene. 1998;17(21):2753-60. [PubMed ID: 9840939]. https://doi.org/10.1038/sj.onc.1202211.